AspergillusInfections in Transplant Recipients
Top Cited Papers
Open Access
- 1 January 2005
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 18 (1) , 44-69
- https://doi.org/10.1128/cmr.18.1.44-69.2005
Abstract
SUMMARY: Aspergillusinfections are occurring with an increasing frequency in transplant recipients. Notable changes in the epidemiologic characteristics of this infection have occurred; these include a change in risk factors and later onset of infection. Management of invasive aspergillosis continues to be challenging, and the mortality rate, despite the use of newer antifungal agents, remains unacceptably high. Performing molecular studies to discern new targets for antifungal activity, identifying signaling pathways that may be amenable to immunologic interventions, assessing combination regimens of antifungal agents or combining antifungal agents with modulation of the host defense mechanisms, and devising diagnostic assays that can rapidly and reliably diagnose infections represent areas for future investigations that may lead to further improvement in outcomes.Keywords
This publication has 315 references indexed in Scilit:
- Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in SerumAntimicrobial Agents and Chemotherapy, 2004
- False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐TazobactamClinical Infectious Diseases, 2004
- Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafunginJournal of Antimicrobial Chemotherapy, 2003
- Delayed Occurrence of Cytomegalovirus Disease in Organ Transplant Recipients Receiving Antiviral Prophylaxis: Are We Winning the Battle Only to Lose the War?European Journal of Clinical Microbiology & Infectious Diseases, 2002
- Antifungal Prophylaxis for Solid Organ Transplant Recipients: Seeking Clarity Amidst ControversyClinical Infectious Diseases, 2000
- Significance of Aspergillemia in Patients with Cancer: A 10-Year StudyClinical Infectious Diseases, 2000
- Invasive Aspergillosis in Mice Immunosuppressed with Cyclosporin A, Tacrolimus (FK506), or Sirolimus (Rapamycin)The Journal of Infectious Diseases, 1997
- Infectious complications in 100 consecutive heart transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Primary Cutaneous Aspergillosis Associated with Hickman Intravenous CathetersNew England Journal of Medicine, 1987